|Bid||1,307.20 x 0|
|Ask||1,308.80 x 0|
|Day's range||1,304.20 - 1,352.31|
|52-week range||1,280.92 - 2,746.59|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||11.45|
|Earnings date||02 Nov 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Certain UK companies earn huge portions of their revenue in US dollars. Could this currency tailwind earn me a dividend-driven passive income boost? The post I’m buying FTSE shares for bonus passive income with a bullish dollar appeared first on The Motley Fool UK.
GSK (GSK) closed at $29.36 in the latest trading session, marking a -0.34% move from the prior day.
(Reuters) -Britain's GSK has appointed its first female chief financial officer, Julie Brown, to succeed Iain Mackay, as the drugmaker focuses on its core pharmaceuticals business. With Emma Walmsley as GSK's chief executive, Brown's appointment also creates a rare, all-female top management at a blue-chip British company and a global pharma major. Brown, who has extensive experience in the health and pharmaceutical industry, will join GSK from luxury fashion brand Burberry, in April and take up the job in May.